Biomarkers for Prostate Cancer

The present invention relates to compositions and methods for the detecting, treating, and empirically investigating the prostate. In particular, the present invention provides compositions and methods for using neuroligin biomarkers (e.g., NLGN-4Y) in the diagnosis, treatment, and empirical investigation of prostate disorders (e.g., prostate cancer, benign prostatic hypertrophy).

Attached files:
20110020230.jpg

Patents:
US 20,110,020,230

Inventor(s): THAXTON COLBY SHAD [US]; SMITH NORM D [US]; PAZONA JOSEPH [US]; OKOTIE ONISURU T [US]

Type of Offer: Licensing



Next Patent »
« More Biotech Patents

Share on      


CrowdSell Your Patent